People: POZEN Inc (POZN.O)
24 Nov 2014
Dr. Seth A. Rudnick, M.D., is an Independent Director of Pozen Inc., since July 25, 2011. He is Venture partner and previously general partner at Canaan Partners, a venture capital firm, since 1998. Formerly, Chief Executive Officer and Chairman of CytoTherapeutics Inc., a company developing stem cell-based therapies. Helped found and served as the Head of Research and Development for Ortho Biotech, a division of Johnson & Johnson focusing on cancer and chronic illnesses from 1991 to 1998. Serves of the Boards of the following privately held biotechnology companies: Chimerix, Inc., Liquidia Technologies, Inc., ORTHOCON, Inc., Spine Wave, Inc. and VaxInnate, Inc. Currently a Clinical Adjunct Professor of Medicine at University of North Carolina, Chapel Hill.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|